1 active not recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Ivonescimab Injection: new trials by email Literature Review of Ivonescimab Injection trials Research Report on Ivonescimab Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 Ivonescimab Injection, Pembrolizumab Injection - Non-Small Cell Lung Cancer | Phase 3 | Recruiting | Summit Therapeutics | 780 | 2025-02-27 | 2026-09-18 |
| Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients Ivonescimab Injection, Pembrolizumab Injection - Non-Small Cell Lung Cancer | Phase 3 | Active not recruiting | Summit Therapeutics | 1600 | 2023-10-26 | 2026-10-08 |
Carcinoma, Non-Small-Cell Lung (2)
Belgium (2) · Canada (2) · China (2) · France (2) · Germany (2) · Greece (2) · Italy (2) · Japan (2) · Mexico (2) · Poland (2) · Serbia (2) · Spain (2) · Turkey (Türkiye) (2) · United States (2) · Hungary (1)
Indu Lal (1)